Sign in
Taking peopleNo phase

Blood clot test using fresh plasma in adults with suspected venous thromboembolism

Compares a decision-support blood test on fresh and frozen plasma in suspected blood clots.

Key facts

Who runs it
Diagnostica Stago R&D
Where
France4 sites in 1 countryChoose a country to see its sites
Trial code
Registry title
Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support
Status
Recruiting
People taking part
1,836 people, planned
Started
21 Jun 2022
Expected to end
Feb 2027
Type of study
Observational
Treatments tested
  • Routine Assays on fresh plasma
  • New Clinical Decision Support on fresh plasma
  • New Clinical Decision Support on frozen plasma
Record updated
26 June 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who may have a blood clot in the lung (pulmonary embolism) or in a deep vein (deep vein thrombosis). It tests a new decision tool on fresh blood plasma.

Age
18 Years and older
Sex
All
Disease stage
Suspected pulmonary embolism and/or deep vein thrombosis, whatever the chance of having it before testing.
Earlier treatment
People cannot join if they are taking blood thinners, either to prevent or to treat clots, or clot-dissolving treatment.

Main reasons for not taking part

  • Taking blood thinners to prevent or treat clots
  • Taking clot-dissolving (fibrinolytic) treatment
  • Under legal protection, such as guardianship or curatorship
  • Pregnant or breastfeeding women
  • Not covered by the social security system

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • PE and/or DVT suspicion
  • No opposition after informing the patient for his participation in research and processing of their data for this purpose,
  • Benefiting from the social security system

Who cannot take part

  • Preventive or curative anticoagulant treatment, or fibrinolytic treatment,
  • Legal protection (e.g. guardianship or curatorship),
  • Pregnant or breastfeeding women

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this non interventional study is to demonstrate the diagnostic performances on fresh plasmas in comparison with the performances on frozen plasmas in any patients with VTE suspicion, whatever the pre-test probability. The main question it aims to answer is :

Read full original descriptionShow less

Are the performances equivalent on fresh plasmas in comparison with frozen plasmas or is it necessary to determine a new algorithm of the Clinical Decision Support with a new cut-off? Participants will be diagnosed and treated in accordance with routine standard of care.

Treatments tested

  • Routine Assays on fresh plasma
  • New Clinical Decision Support on fresh plasma
  • New Clinical Decision Support on frozen plasma

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support With Fresh Plasma, on Any Patient With VTE Suspicion
Plain-language title
Blood clot test using fresh plasma in adults with suspected venous thromboembolismGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
26 June 2025